Literature DB >> 35221712

Predictors of COVID-19 Hospital Treatment Outcome.

Ryszard Tomasiuk1, Jan Dabrowski2, Jolanta Smykiewicz3, Magdalena Wiacek4.   

Abstract

BACKGROUND: There are more than 228,394,572 confirmed cases and 4,690,186 confirmed deaths caused by COVID-19 worldwide. The magnitude of the COOVID-19 pandemic has stimulated research on the treatment and diagnosis of COVID-19 patients.
OBJECTIVE: In this report, a battery of specific parameters was used to develop a model that allows prediction of the outcome of the COVID-19 treatment. These parameters are C-reactive protein, procalcitonin, fibrinogen, D-dimers, immature granulocytes, and interleukin-6.
METHODS: The study was carried out on a sample of N = 49 survivors (22 men, 27 women) and 83 deceased patients (62 men, 21 women). The distribution of means and differences in means of the parameters studied between survivors and deceased patients were evaluated using the bootstrap method.
RESULTS: A mathematical model that allows for the prediction of hospitalization outcome was obtained using the Naive Bayes model. The results demonstrated a statistically significant difference between survivors and deceased patients in all parameters studied. A mathematical model employing a battery of parameters provided a 97% precision in predicting the outcome of hospitalization.
CONCLUSION: This study showed that the cross-correlation of survivability with absolute levels of C-reactive protein, procalcitonin, fibrinogen, D-dimers, immature granulocytes, and interleukin-6 could be used successfully in the hospital setting as a diagnostic tool.
© 2021 Tomasiuk et al.

Entities:  

Keywords:  C-reactive protein; Covid-19; D-dimers; biological markers; fibrinogen; immature granulocytes; interleukin-6; procalcitonin

Year:  2021        PMID: 35221712      PMCID: PMC8866999          DOI: 10.2147/IJGM.S334544

Source DB:  PubMed          Journal:  Int J Gen Med        ISSN: 1178-7074


  36 in total

1.  Age-dependent reference ranges for automated assessment of immature granulocytes and clinical significance in an outpatient setting.

Authors:  Michael H A Roehrl; Donald Lantz; Crystal Sylvester; Julia Y Wang
Journal:  Arch Pathol Lab Med       Date:  2011-04       Impact factor: 5.534

2.  Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenemia.

Authors:  W Miesbach; J Schenk; S Alesci; E Lindhoff-Last
Journal:  Thromb Res       Date:  2010-10-13       Impact factor: 3.944

3.  C-reactive protein levels determine the severity of soft-tissue injuries.

Authors:  J W Pritchett
Journal:  Am J Orthop (Belle Mead NJ)       Date:  1996-11

Review 4.  Biology of COVID-19 and related viruses: Epidemiology, signs, symptoms, diagnosis, and treatment.

Authors:  Alan D Kaye; Elyse M Cornett; Kimberley C Brondeel; Zachary I Lerner; Haley E Knight; Abigail Erwin; Karina Charipova; Kyle L Gress; Ivan Urits; Richard D Urman; Charles J Fox; Christopher G Kevil
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2020-12-08

5.  The course of C-reactive protein response in untreated upper respiratory tract infection.

Authors:  Hasse Melbye; Dag Hvidsten; Arne Holm; Sveine Arne Nordbø; Jan Brox
Journal:  Br J Gen Pract       Date:  2004-09       Impact factor: 5.386

6.  C-reactive protein as an early predictor of COVID-19 severity.

Authors:  Maryame Ahnach; Saad Zbiri; Sara Nejjari; Fadwa Ousti; Chafik Elkettani
Journal:  J Med Biochem       Date:  2020-10-02       Impact factor: 3.402

7.  Early identification of intensive care unit-acquired infections with daily monitoring of C-reactive protein: a prospective observational study.

Authors:  Pedro Póvoa; Luís Coelho; Eduardo Almeida; Antero Fernandes; Rui Mealha; Pedro Moreira; Henrique Sabino
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

8.  Enhancing ontology-driven diagnostic reasoning with a symptom-dependency-aware Naïve Bayes classifier.

Authors:  Ying Shen; Yaliang Li; Hai-Tao Zheng; Buzhou Tang; Min Yang
Journal:  BMC Bioinformatics       Date:  2019-06-13       Impact factor: 3.169

9.  Role of interleukin 6 as a predictive factor for a severe course of Covid-19: retrospective data analysis of patients from a long-term care facility during Covid-19 outbreak.

Authors:  P Sabaka; A Koščálová; I Straka; J Hodosy; R Lipták; B Kmotorková; M Kachlíková; A Kušnírová
Journal:  BMC Infect Dis       Date:  2021-03-29       Impact factor: 3.090

10.  Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis.

Authors:  Leiwen Fu; Bingyi Wang; Tanwei Yuan; Xiaoting Chen; Yunlong Ao; Thomas Fitzpatrick; Peiyang Li; Yiguo Zhou; Yi-Fan Lin; Qibin Duan; Ganfeng Luo; Song Fan; Yong Lu; Anping Feng; Yuewei Zhan; Bowen Liang; Weiping Cai; Lin Zhang; Xiangjun Du; Linghua Li; Yuelong Shu; Huachun Zou
Journal:  J Infect       Date:  2020-04-10       Impact factor: 6.072

View more
  2 in total

1.  Hybrid Bayesian Network-Based Modeling: COVID-19-Pneumonia Case.

Authors:  Ilia Vladislavovich Derevitskii; Nikita Dmitrievich Mramorov; Simon Dmitrievich Usoltsev; Sergey V Kovalchuk
Journal:  J Pers Med       Date:  2022-08-17

2.  Serum ACE2 Level is Associated With Severe SARS-CoV-2 Infection: A Cross-Sectional Observational Study.

Authors:  Amjad Bani Hani; Nafez Abu Tarboush; Mo'ath Bani Ali; Fahad Alabhoul; Fahad Alansari; Ahmad Abuhani; Mustafa Al-Kawak; Badea'a Shamoun; Suzan Albdour; Mahmoud Abu Abeeleh; Mamoun Ahram
Journal:  Biomark Insights       Date:  2022-09-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.